ATM and mantle cell lymphoma: ATR inhibition has been shown to be lethal in ATM‐ and p53‐deficent cells (i.e., chronic lymphocytic leukemia, pancreatic adenocarcinoma, mantle cell lymphoma, and gastric cancer cells) and the molecular mechanisms underlying seem to depend on the specific cell type.37, 153, 154, 155, 156